Broperamole

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H18BrN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G5MIG3753N, chemically known as piperidine, 1-(3-(5-(3-bromophenyl)-2h-tetrazol-2-yl)-1-oxopropyl)- but generally known as broperamole, which bears US NIH Compound Identifier 36341. European Medicines Agency schedules Broperamole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05927MIG. The term BROPERAMOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). BROPERAMOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule broperamole under HS 29333999 and SITC 51574. As of Q4 2014, BROPERAMOLE remains the US FDA Preferred Term for this commodity. Broperamole bears US NLM identifiers UMLS ID C0054149 and NCI Concept Code C76797. SMILES: BRC1CC(C2NN(NN2)CCC(=O)N2CCCCC2)CCC1.